421
Participants
Start Date
April 30, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Quetiapine fumarate XR
Quetiapine XR (extended release) will be administered once daily at bedtime in oral tablet form, Day 1: 50 mg, Day 2: 100 mg, Day 3: 200 mg, Day 4 onwards: 300 mg.
Lithium carbonate
Twice daily from Day 1 to Day 56. From Day 1 to Day 7, the total daily dose of lithium could be increased gradually within the dose range 300 mg/day to 1800 mg/day. From Day 8 to Day 56, the total daily dose could be adjusted from 600 to 1800 mg/day
Research Site, La Plata
Research Site, Godoy Cruz
Research Site, Mendoza
Research Site, Caba
Research Site, Aparecida de Goiânia
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, Santiago
Research Site, Medellín
Research Site, Bogota D.c
Research Site, Guatemala City
Research Site, Monterrey
Research Site, San Luis Potosí City
Research Site, Durango
Research Site, Monterrey
Research Site, Lima
Research Site, Ankara
Research Site, Elâzığ
Research Site, Istanbul
Research Site, Izmir
Research Site, Kocaeli
Research Site, Malatya
Research Site, Manisa
Research Site, Caracas
Lead Sponsor
AstraZeneca
INDUSTRY